HYPR · Hyperfine, Inc.

The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Wolterman's continued service through the applicable vesting date.

The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 31, 2025 pursuant to a "sell to cover" provision included in the RSU Agreement.

Represents the weighted average sales price per share. The shares sold at prices ranging from $1.63 to $1.715 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

The sales reported in ths Form 4 were effected to cover tax witholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 31, 2025 pursuant to a "sell to over" provision included in the RSU agreement.

Represents the weighted average sales price per share. The shares sold at prices ranging from $1.63 to $1.715 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Dahldorf's continued service through the applicable vesting date.

The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Ms. Fattori's continued service through the applicable vesting date.

The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Dr. Rothberg's continued service through the applicable vesting date.

The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Wolterman's continued service through the applicable vesting date.

Consist of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest 25% on March 23, 2027, with the remainder vesting in equal quarterly installments over the following three years, subject to Ms. Sainz's continued service through the applicable vesting date.

Consists of 750,000 RSUs granted on March 31, 2026 plus 19,586 shares received on vesting of an RSU award granted on December 23, 2021 and an aggregate of 20,000 purchased shares.

Consist of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest 25% on March 23, 2027, with the remainder vesting in equal quarterly installments over the following three years, subject to Dr. Teisseyre's continued service through the applicable vesting date.

Consist of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest 25% on March 23, 2027, with the remainder vesting in equal quarterly installments over the following three years, subject to Mr Hale's continued service through the applicable vesting date.

The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 31, 2025 pursuant to a "sell to cover" provision included in the RSU Agreement.

The sales reported in ths Form 4 were effected to cover tax witholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 31, 2025 pursuant to a "sell to over" provision included in the RSU agreement.

The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 28, 2022 and April 28, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 28, 2022 and April 28, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 28, 2022 and April 28, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Wolterman's continued service through the vesting date. During the vesting term of the option, Mr. Wolterman will not receive cash compensation for his service as Chairperson of the Board of Directors.

The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Dahldorf's continued service through the applicable vesting date.

The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Ms. Fattori's continued service through the applicable vesting date.

The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Wolterman's continued service through the applicable vesting date.

The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 28, 2022 and April 28, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest 25% on March 23, 2026, with the remainder vesting in equal quarterly installment over the following three years, subject to the employee's continued service to the Company through the applicable vesting dates, subject to Mr. Hale's continued service through the applicable vesting date.

Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest 25% on March 23, 2026, with the remainder vesting in equal quarterly installment over the following three years, subject to the employee's continued service to the Company through the applicable vesting dates, subject to Dr. Teisseyre's continued service through the applicable vesting date.

The sales reported in this amended Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 28, 2022 and April 28, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 28, 2022 and April 28, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 28, 2022 and April 28, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Huennekens' continued service through the applicable vesting date.

The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Dr. Rothberg's continued service through the applicable vesting date.

The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Dahldorf's continued service through the applicable vesting date.

The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Ms. Fattori's continued service through the applicable vesting date.

The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Wolterman's continued service through the applicable vesting date.

The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 28, 2022 and April 28, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

The shares underlying this option vest as to 25% on March 28, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to Ms. Sainz's continued service through the applicable vesting date.

The shares underlying this option vest as to 25% on March 28, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to Mr. Hale's continued service through the applicable vesting date.

The shares underlying this option vest as to 25% on March 28, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to Dr. Teisseyre's continued service through the applicable vesting date.

The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 28, 2022 and April 28, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 28, 2022 and April 28, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 29, 2022 and April 28, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 29, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

The shares underlying this option vest as to 25% of the shares on July 24, 2024, with the remainder vesting in 36 equal monthly installments thereafter, subject to Dr. Teisseyre's continued service through the applicable vesting date.

The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Dahldorf's continued service through the applicable vesting date.

The shares underlying this option vest as to 50% on June 9, 2024 and the remaining 50% on June 9, 2025, subject to Ms. Fattori's continued service through the applicable vesting date.

The shares underlying this option vest 100% on June 9, 2028, subject to Mr. Huennekens' continued service through the vesting date.

The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Huennekens' continued service through the applicable vesting date.

The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Dr. Rothberg's continued service through the applicable vesting date.

The shares underlying this option vest as to 50% on June 9, 2024 and the remaining 50% on June 9, 2025, subject to Mr. Wolterman's continued service through the applicable vesting date.

The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Wolterman's continued service through the applicable vesting date.

On June 9, 2023, Mr. Huennekens was granted a new stock option to purchase 237,437 shares of the Issuer's Class A common stock reported below that was contingent upon the cancellation of this stock option.

The shares underlying this option vest and will become exercisable upon the first to occur of the following: (1) the completion of a SPAC transaction within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share of $30.00 or more for at least 20 out of 30 consecutive trading days within four years of the closing of the SPAC transaction; (2) the completion of an IPO within two years of Mr. Huennekens' start date and the Issuer's common stock achieving a closing price per share that equals or exceeds 3.0 times $3.92 (as adjusted) within four years of the closing of the IPO; or (3) the closing of a private financing round within four years of Mr. Huennekens' start date in which $50 million or more is raised and Hyperfine's stock price per share equals or exceeds 3.0 times $3.92 (as adjusted).

The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Ms. Fattori's continued service through the applicable vesting date.

The shares underlying this option vest as to 50% on June 9, 2024 and the remaining 50% on June 9, 2025, subject to Mr. Dahldorf's continued service through the applicable vesting date.

The shares underlying this option vest as to 25% of the shares on May 23, 2024, with the remainder vesting in 36 equal monthly installments thereafter, subject to Dr. Siddiqui's continued service through the applicable vesting date.